Brokerages predict that AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) will report $2.36 million in sales for the current fiscal quarter, Zacks reports. Two analysts have issued estimates for AcelRx Pharmaceuticals’ earnings, with estimates ranging from $1.5 million to $3.22 million. AcelRx Pharmaceuticals reported sales of $3.03 million in the same quarter last year, which would suggest a negative year-over-year growth rate of 22.1%. The company is scheduled to issue its next earnings results after the market closes on Monday, May 8th.On average, analysts expect that AcelRx Pharmaceuticals will report full-year sales of $2.36 million for the current fiscal year, with estimates ranging from $7.1 million to $11.4 million. For the next fiscal year, analysts forecast that the company will post sales of $28.3 million per share, with estimates ranging from $16 million to $40.6 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that that provide coverage for AcelRx Pharmaceuticals.http://bit.ly/2qRE64P